NCT06527898View on ClinicalTrials.gov

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Small-cell Lung Cancer
Interventions
DRUG

hypofractionated radiotherapy with immunotherapy

hypofractionated radiotherapy with Adebrelimab consolidation

Trial Locations (1)

230011

RECRUITING

Anhui Provicial Hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV